InvestorsHub Logo
Followers 0
Posts 238
Boards Moderated 0
Alias Born 09/24/2012

Re: None

Monday, 10/17/2016 11:13:31 AM

Monday, October 17, 2016 11:13:31 AM

Post# of 9558
I,ve been following the progress of a company whose progress in the detection of colorectal cancer may have a negative effect on the value of MHTX shares. The company is VolitionRX Ltd (stock symbol: VNRX). Their technology is a blood test which they claim has a 97% detection rate of colon cancer. I suggest we all follow the web postings of VNRX to monitor their progress. I recognize that blood test are incapable of finding the exact location of a tumor. However, I can't help thinking their technology will have a negative effect on wide usage of the MRX technology.